Home Duke University Press
 QUICK SEARCH:   [advanced]


     
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Neuro Oncol 2004 6(2):83-95; DOI:10.1215/S1152851703000140
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gomez, G. G.
Right arrow Articles by Kruse, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Duke University Press

Tumor Biology

Interactions of the allogeneic effector leukemic T cell line, TALL-104, with human malignant brain tumors

German G. Gomez, Susana B. Read, Lazaro E. Gerschenson, Daniela Santoli, Adam Zweifach and Carol A. Kruse2

Departments of Pathology (G.G.G., L.E.G., C.A.K.), Immunology (S.B.R., A.Z., C.A.K.), and Physiology (A.Z.), University of Colorado Health Sciences Center, Denver, CO 80262, and The Wistar Institute (D.S.), Philadelphia, PA 19104; USA

2 Address correspondence to Carol A. Kruse, Department of Immunology, Campus Box B216, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Denver, CO 80262 (carol.kruse{at}uchsc.edu).

Abstract

TALL-104 is a human leukemic T cell line that expresses markers characteristic of both cytotoxic T lymphocytes and natural killer cells. TALL-104 cells are potent tumor killers, and the use of lethally irradiated TALL-104 as cellular therapy for a variety of tumors has been explored. We investigated the interactions of TALL-104 cells with human brain tumor cells. TALL-104 cells mediated increased lysis of a panel of brain tumor cells at low effector-to-target ratios over time. We obtained evidence that TALL-104 cells injured glioma cells by both apoptotic and necrotic pathways. A 7-amino actinomycin D flow cytometry assay revealed that the percentages of both apoptotic and necrotic glioma cells increased after TALL-104 cell/glioma cell coincubations. Fluorescent microscopy studies and a quantitative morphologic assay confirmed that TALL-104 cell/glioma cell interactions resulted in tumor cell apoptosis. Cytokines are secreted when TALL-104 cells are coincubated with brain tumor cells; however, morphologic analysis assays revealed that the soluble factors contained within clarified supernates obtained from 4 h coincubates added back to brain tumor cell cultures did not trigger the glioma apoptosis. TALL-104 cells do not express Fas ligand, even upon coincubation with glioma targets, which suggests that the Fas/Fas ligand apoptotic pathway is not likely responsible for the cell injury observed. We obtained evidence that cell injury is calcium dependent and that lytic granule exocytosis is triggered by contact of TALL-104 cells with human glioma cells, suggesting that this pathway mediates glioma cell apoptosis and necrosis.







  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Copyright 2004 by Society for Neuro-Oncology